Lemaitre Vascular (LMAT) Equity Average (2011 - 2026)

Lemaitre Vascular (LMAT) has 16 years of Equity Average data on file, last reported at $400.1 million in Q1 2026.

• Equity Average for Q1 2026 came in at $400.1 million, up 16.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $400.1 million (up 16.83% YoY), and the FY2025 annual result was $365.4 million, up 15.05% from the prior year.
• Equity Average improved to $400.1 million in Q1 2026 per LMAT's latest filing, from $386.2 million in the prior quarter.
• Over five years, Equity Average peaked at $400.1 million in Q1 2026 and troughed at $256.0 million in Q1 2022.
• A 5-year average of $311.7 million and a median of $303.2 million in 2024 frame the typical range for Equity Average.
• On a YoY basis, Equity Average climbed as much as 46.23% in 2022 and fell as far as 5.22% in 2022.
• A 5-year view of Equity Average shows it stood at $264.7 million in 2022, then rose by 10.78% to $293.3 million in 2023, then rose by 13.95% to $334.2 million in 2024, then grew by 15.57% to $386.2 million in 2025, then gained by 3.59% to $400.1 million in 2026.
• Business Quant data shows LMAT's Equity Average at $400.1 million in Q1 2026, $386.2 million in Q4 2025, and $370.8 million in Q3 2025.